Augmentationh de capital

  • Accès interdit aux États-Unis d’Amérique, au Canada, au Japon, à l’Afrique du Sud et à l’Australie.

11/23/2023

Letter to Shareholders – November 2023

11/09/2023

ADOCIA Revealed Promising Preclinical Data on AdoShell® Islets for Cell Therapy of Diabetes

10/25/2023

ADOCIA Reports Financial Results of Third Quarter 2023 and Provides an Update on its Activities

10/23/2023

ADOCIA’s Partner Tonghua Dongbao Announces Positive Results of Three Clinical Trials on BioChaperone® Combo

09/25/2023

ADOCIA Announces Oral Presentations on AdoShell® Islets at EASD and IPITA-IXA-CTRMS Congresses